近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688137 近岸蛋白

已收盘 07-25 15:00:01

{"stockData":{"symbol":"688137","market":"SH","secType":"STK","nameCN":"近岸蛋白","latestPrice":46.51,"timestamp":1753426801000,"preClose":45.6,"halted":0,"volume":2490631,"delay":0,"changeRate":0.02,"floatShares":32675400,"shares":70175400,"eps":-0.9063,"marketStatus":"已收盘","change":0.91,"latestTime":"07-25 15:00:01","open":45.11,"high":46.98,"low":44.77,"amount":114000000,"amplitude":0.0485,"askPrice":46.51,"askSize":2,"bidPrice":46.5,"bidSize":34,"shortable":0,"etf":0,"ttmEps":-0.9063,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":45.6,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":50.16,"lowLimit":41.04,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":70175439,"isCdr":false,"pbRate":1.56,"roa":"--","roe":"--","epsLYR":-0.78,"committee":-0.102564,"marketValue":3264000000,"turnoverRate":0.0762,"status":0,"afterMarket":{"amount":9302,"volume":200,"close":46.51,"buyVolume":800,"sellVolume":0,"time":1753428838020,"indexStatus":"已收盘 07-25 15:30:00","preClose":45.6},"floatMarketCap":1520000000},"requestUrl":"/m/hq/s/688137","defaultTab":"news","newsList":[{"id":"2553215593","title":"近岸蛋白今日主力净流出289.5万 业绩压力压制股价短期走势","url":"https://stock-news.laohu8.com/highlight/detail?id=2553215593","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553215593?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:22","pubTimestamp":1753255332,"startTime":"0","endTime":"0","summary":"近岸蛋白今日主力资金净流出132.9万元，连续6日净流出，累计流出压力持续。主力资金持续撤离可能反映机构对短期走势的谨慎态度，或将对股价形成一定压制。资金面与市场情绪共振引发波动近岸蛋白主力资金连续多日净流出，截至7月23日，单日主力净流出289.5万元，与公司2025年前三季度归母净利润同比下滑348.91%的业绩压力形成共振。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723152430a45e365c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723152430a45e365c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2552417136","title":"每周股票复盘：近岸蛋白（688137）股东户数增至6505户，增幅4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552417136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552417136?lang=zh_cn&edition=full","pubTime":"2025-07-20 04:26","pubTimestamp":1752956768,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，近岸蛋白报收于45.36元，较上周的39.2元上涨15.71%。本周，近岸蛋白7月15日盘中最高价报50.87元，股价触及近一年最高点。本周关注点股本股东变化：截至2025年7月10日公司股东户数为6505.0户，较6月30日增加272.0户，增幅为4.36%股本股东变化近日近岸蛋白披露，截至2025年7月10日公司股东户数为6505.0户，较6月30日增加272.0户，增幅为4.36%。户均持股数量由上期的1.13万股减少至1.08万股，户均持股市值为42.68万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2551314560","title":"7月16日近岸蛋白跌6.48%，鑫元专精特新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551314560","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551314560?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:12","pubTimestamp":1752653555,"startTime":"0","endTime":"0","summary":"证券之星消息，7月16日近岸蛋白跌6.48%，收盘报45.45元，换手率17.94%，成交量5.86万手，成交额2.64亿元。重仓近岸蛋白的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为鑫元基金的鑫元专精特新混合A。该公募基金现任基金经理为陆杨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600025191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2551115959","title":"近岸蛋白股价下跌5.45% 业绩下滑叠加资金分流","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115959","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551115959?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:32","pubTimestamp":1752629547,"startTime":"0","endTime":"0","summary":"近岸蛋白股价大幅下跌，最新价45.95元/股，跌幅5.45%。资金博弈与市场情绪共振近岸蛋白净流入受主力资金高频博弈影响显著。截至7月15日，主力资金连续两日净流入累计达3318.7万元，显示短期资金面转向活跃。2025年前三季度归母净利润同比下滑348.91%，基本面压力引发部分机构调仓避险。叠加生物制品板块资金向创新药赛道分流，板块内部分化加剧个股波动。此外，股东户数增至6223户，户均持股环比下降5.4%，筹码分散化趋势削弱股价稳定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093703a6ac377c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093703a6ac377c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2551365154","title":"近岸蛋白截止07月10日股东人数6505.00户，人均持股5023.13股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551365154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551365154?lang=zh_cn&edition=full","pubTime":"2025-07-15 15:15","pubTimestamp":1752563706,"startTime":"0","endTime":"0","summary":"近岸蛋白披露公司股东人数最新情况，截止2025年07月10日，公司股东人数为6505.00户，较上期增加272户，环比增长4.36%。在生物制品行业个股中，近岸蛋白股东户数少于行业平均水平，截至2025年07月10日，生物制品行业平均股东户数为3.66万户，户均持股市值方面，生物制品行业A股上市公司户均持股市值为89.14万元，近岸蛋白少于行业平均水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715151509a6aa7859&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715151509a6aa7859&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2551697010","title":"细胞免疫治疗概念盘中拉升，近岸蛋白涨8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551697010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551697010?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:56","pubTimestamp":1752476216,"startTime":"0","endTime":"0","summary":"07月14日，细胞免疫治疗概念盘中拉升，截至14点56分，细胞免疫治疗概念整体指数上涨1.03%，报958.390点。从个股上来看，该概念的成分股中，近岸蛋白涨8.21%，冠昊生物、泰林生物等3只股涨幅超过5%。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为-2.09亿，其中华海药业受到资金热捧，主力净流入8537.59万；拉长时间线来看，该板块近20日主力资金净流入-38.85亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714145656a6a803fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714145656a6a803fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","688137","BK0188","BK0216","BK0239","BK0185","BK0012","BK0028","BK0201","BK0070"],"gpt_icon":0},{"id":"2551979879","title":"近岸蛋白涨5.89% 生物制品资金分流叠加筹码分散","url":"https://stock-news.laohu8.com/highlight/detail?id=2551979879","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551979879?lang=zh_cn&edition=full","pubTime":"2025-07-14 13:03","pubTimestamp":1752469397,"startTime":"0","endTime":"0","summary":"近岸蛋白股价大幅上涨，最新价报41.51元/股，涨跌幅为5.89%。资金博弈与市场情绪共振近岸蛋白净流入与多空资金博弈密切相关。截至7月14日13时，该股当日主力资金净流入109.95万元，但7月11日仍录得净流出558.7万元，显示短期筹码存在分歧。2025年前三季度归母净利润同比下滑348.91%，业绩压力促使部分机构调仓离场。此外，生物制品板块资金近期向创新药赛道分流，叠加股东户数增至6223户、户均持股环比下降5.4%，筹码分散化趋势进一步削弱股价稳定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714130320a6a7db62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714130320a6a7db62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2550636509","title":"近岸蛋白今日主力净流出420.8万 短期受压中长期有望突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2550636509","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550636509?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:02","pubTimestamp":1752048126,"startTime":"0","endTime":"0","summary":"近岸蛋白今日主力资金净流出420.8万元，连续4日净流出，上一交易日主力净流出207.1万元。主力资金持续流出可能反映市场短期信心偏弱，或对股价形成一定压力。资金面与市场情绪共振引发短期波动近期近岸蛋白主力资金呈现多空博弈态势，截至2025年7月9日，三个交易日累计净流出超1600万元。此外，股东户数增至6223户，户均持股环比下降5.4%，筹码分散化趋势进一步压制短期反弹动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709162836a69ef5d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709162836a69ef5d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2549528577","title":"近岸蛋白：股东菏泽乔贝和上海普近拟减持不超过0.61%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528577","media":"蓝鲸财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549528577?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:42","pubTimestamp":1751982174,"startTime":"0","endTime":"0","summary":"蓝鲸新闻7月8日电，近岸蛋白(688137.SH)公告称，股东菏泽乔贝和上海普近因自身经营发展和资金需求，计划通过集中竞价、大宗交易等方式减持所持公司部分股份，减持价格按市场价格确定，减持期间为自公告披露之日起3个交易日后的三个月内。菏泽乔贝拟减持不超过161,959股，占公司总股本的0.2308%；上海普近拟减持不超过263,158股，占公司总股本的0.3750%。两者合计拟减持不超过0.6058%的公司股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214420979e6567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214420979e6567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2548879305","title":"7月3日近岸蛋白涨6.43%，鑫元专精特新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548879305","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548879305?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:27","pubTimestamp":1751531244,"startTime":"0","endTime":"0","summary":"证券之星消息，7月3日近岸蛋白涨6.43%创60日新高，收盘报41.69元，换手率9.18%，成交量3.0万手，成交额1.25亿元。重仓近岸蛋白的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为鑫元基金的鑫元专精特新混合A。该公募基金现任基金经理为陆杨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300026107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2548840438","title":"新冠检测概念盘中拉升，美诺华涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2548840438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548840438?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:03","pubTimestamp":1751508238,"startTime":"0","endTime":"0","summary":"07月03日，新冠检测概念盘中拉升，截至10点03分，新冠检测概念整体指数上涨1.01%，报876.740点。从个股上来看，该概念的成分股中，美诺华涨停，近岸蛋白、热景生物2只股涨幅超过5%。从资金上来看，截止发稿，新冠检测概念主力净流入为-1.89亿，其中热景生物受到资金热捧，主力净流入2716.13万；拉长时间线来看，该板块近20日主力资金净流入-74.68亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031003589534a338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031003589534a338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","603538","BK0239"],"gpt_icon":0},{"id":"2548847237","title":"合成生物概念盘中拉升，美诺华涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548847237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548847237?lang=zh_cn&edition=full","pubTime":"2025-07-03 09:51","pubTimestamp":1751507519,"startTime":"0","endTime":"0","summary":"07月03日，合成生物概念盘中拉升，截至09点51分，合成生物概念整体指数上涨0.50%，报1192.980点。从个股上来看，该概念的成分股中，美诺华涨7.12%，天宇股份、近岸蛋白2只股涨幅超过5%。从资金上来看，截止发稿，合成生物概念主力净流入为-1.86亿，其中牧原股份受到资金热捧，主力净流入2136.19万；拉长时间线来看，该板块近20日主力资金净流入-109.92亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095159a4cc340e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095159a4cc340e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603538","BK0239","688137","BK0216"],"gpt_icon":0},{"id":"2548384049","title":"近岸蛋白涨5.05% 资金博弈与估值分歧驱动震荡","url":"https://stock-news.laohu8.com/highlight/detail?id=2548384049","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548384049?lang=zh_cn&edition=full","pubTime":"2025-07-03 09:50","pubTimestamp":1751507422,"startTime":"0","endTime":"0","summary":"近岸蛋白股价大幅上涨，最新价41.15元/股，涨跌幅为5.05%。资金博弈与估值分歧驱动股价震荡近岸蛋白近期股价波动显著，短期诱因呈现多维度特征。2025年前三季度归母净利润同比下滑348.91%的业绩压力，叠加动态市盈率-61.14倍的估值困境，加剧市场避险情绪。考虑到动态市盈率仍处深度负值区间，后续走势需基本面改善持续验证，投资者宜关注三季报经营数据与产业政策落地节奏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095029a4cc3349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095029a4cc3349&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2548684238","title":"近岸蛋白截止06月30日股东人数6233.00户，人均持股5242.33股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548684238","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548684238?lang=zh_cn&edition=full","pubTime":"2025-07-02 15:14","pubTimestamp":1751440486,"startTime":"0","endTime":"0","summary":"近岸蛋白披露公司股东人数最新情况，截止2025年06月30日，公司股东人数为6233.00户，较上期增加10户，环比增长0.16%。在生物制品行业个股中，近岸蛋白股东户数少于行业平均水平，截至2025年06月30日，生物制品行业平均股东户数为3.62万户，户均持股市值方面，生物制品行业A股上市公司户均持股市值为82.18万元，近岸蛋白少于行业平均水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702151451a729fd6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702151451a729fd6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2548072293","title":"近岸蛋白加快出海步伐 境外收入有望进一步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2548072293","media":"e公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548072293?lang=zh_cn&edition=full","pubTime":"2025-07-01 17:28","pubTimestamp":1751362080,"startTime":"0","endTime":"0","summary":"2024年度，近岸蛋白实现营业收入1.28亿元，同比下降16.73%，实现归属母公司所有者净利润-5441.63万元，同比下降523.68%。在回应海外市场业务拓展情况时，近岸蛋白表示，公司加快海外市场拓展的步伐，在团队搭建、渠道建设、客户拓展和供应链管理等方面取得实质性进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070117295295325fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070117295295325fdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2548079981","title":"7月1日近岸蛋白涨5.25%，鑫元专精特新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548079981","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548079981?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:25","pubTimestamp":1751358336,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日近岸蛋白涨5.25%创60日新高，收盘报40.31元，换手率8.58%，成交量2.8万手，成交额1.13亿元。重仓近岸蛋白的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为鑫元基金的鑫元专精特新混合A。鑫元专精特新混合A目前规模为0.91亿元，最新净值0.5897，较上一交易日上涨0.91%，近一年上涨30.03%。该公募基金现任基金经理为陆杨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100026720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2547056083","title":"近岸蛋白放量冲高涨5.02% 资金分歧与业绩承压共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2547056083","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547056083?lang=zh_cn&edition=full","pubTime":"2025-06-30 13:30","pubTimestamp":1751261429,"startTime":"0","endTime":"0","summary":"近岸蛋白今日股价大幅上涨，截至13点29分，报38.48元/股，涨幅达5.02%，盘中呈现放量冲高态势。成交金额为3271万元，换手率2.67%，创近期多个交易日以来新高，资金积极介入迹象明显。资金面与业绩压力共振引发波动近岸蛋白近期股价波动与资金面变化密切相关。截至6月26日，该股近20个交易日主力资金累计净流出2501.5万元，其中15个交易日呈现净流出态势。2024年年报显示，其生命科学及体外诊断业务占比超70%，受益于国产替代深化与科研投入增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630133039a72548b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630133039a72548b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2546968726","title":"近岸蛋白获得发明专利授权：“一种猴痘病毒多抗原单价疫苗及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2546968726","media":"证券之星企业动态","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546968726?lang=zh_cn&edition=full","pubTime":"2025-06-28 02:50","pubTimestamp":1751050244,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示近岸蛋白新获得一项发明专利授权，专利名为“一种猴痘病毒多抗原单价疫苗及其应用”，专利申请号为CN202510229439.X，授权日为2025年6月27日。本发明将A35R，M1R，A29L，B6R进行合理的抗原组合设计为一个蛋白分子，制备成单价mRNA疫苗。实验结果表明，本发明的mRNA疫苗可确保靶蛋白在体内高效表达，并且能够诱导高水平的中和抗体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280258329791b7f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280258329791b7f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","159646","688137"],"gpt_icon":0},{"id":"2546092472","title":"近岸蛋白：截至2025年5月30日股东总数为6,223名","url":"https://stock-news.laohu8.com/highlight/detail?id=2546092472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546092472?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:37","pubTimestamp":1750923439,"startTime":"0","endTime":"0","summary":"证券之星消息，近岸蛋白(688137)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司5月底最新股东人数，谢谢！近岸蛋白回复：尊敬的投资者，您好！根据中国证券登记结算有限责任公司下发的股东名册，截至2025年5月30日，公司合并普通账户和融资融券信用账户后的股东总数为6,223名。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600019873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2546201210","title":"近岸蛋白：自2021年以来公司创新性地将AI工具与自主研发的机器学习系统深度融合提高了研发创新的效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2546201210","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546201210?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:33","pubTimestamp":1750923181,"startTime":"0","endTime":"0","summary":"自2021年以来，公司创新性地将AI工具与自主研发的机器学习系统深度融合，提高了研发创新的效率，广泛应用于酶、抗体等蛋白质的创新设计、改造和表达，以及抗体亲和力和稳定性改造噬菌体库等技术领域。公司将继续深化AI技术在研发、生产及经营管理等业务流程中的应用，不断完善和升级信息系统建设，以提高工作效率，加强风险管控，全面提升运营管理的智能化和信息化水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626154603a71e6d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626154603a71e6d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688137"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753453026391,"stockEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":0.2422},{"period":"3month","weight":0.3907},{"period":"6month","weight":0.4518},{"period":"1year","weight":0.562},{"period":"ytd","weight":0.3735}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.0943},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.2425},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州近岸蛋白质科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"7165人(较上一季度增加10.15%)","perCapita":"4560股","listingDate":"2022-09-29","address":"江苏省苏州市吴江区吴江经济技术开发区云创路228号3层,4层","registeredCapital":"7017万元","survey":"　　苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产和销售及提供生物药、体外诊断、mRNA疫苗药物、生命科学基础研究等领域的全流程应用解决方案。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。","listedPrice":106.19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"近岸蛋白,688137,近岸蛋白股票,近岸蛋白股票老虎,近岸蛋白股票老虎国际,近岸蛋白行情,近岸蛋白股票行情,近岸蛋白股价,近岸蛋白股市,近岸蛋白股票价格,近岸蛋白股票交易,近岸蛋白股票购买,近岸蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}